Abstract:Introduction New interest emerges on organoids for studying lung diseases, mainly chronic obstructive pulmonary disease (COPD). COPD is lung disease a characterize by chronic inflammation and excessive remodeling in small airway. The complexity of this disease is now widely recognized, cellular-based research remains highly challenging because of the lack of suitable experimental models that recapitulate between interaction of cells. Alveolar organoids could enable us to assess the involvement of several type cells in response to damage from cigarette smoke, one major risk factor of COPD. The aim of this study is to characterize an in vitro 3D alveolar model from mouse lungs. Methods We used progenitor cells isolated by filtration from pieces of mouse lung and cultivated in Matrigel. We cultivated first part of lung organoids in conditioned expansion medium for ten days. After another part of organoids were differentiated in conditioned differentiation alveolar medium during ten days. Then, we assessed several markers of alveolar cells differentiated, fibroblast markers, or stem cell markers gene expression by RT-qPCR in the two conditions. Results The markers used are as follow: (1) aquaporin 5 (Aqp5), homeodomain-only protein homeobox (Hopx), advanced glycation endproduct-specific receptor (Ager) and podoplanin (Pdpn) for alveolar type 1 (AT1); (2) surfactant protein b (Sfptb), surfactant protein c (Sfptc) for alveolar type 2 (AT2); (3) platelet-derived growth factor alpha (Pdgfrα) for fibroblast; (4) secretoglobin family 1A member 1 (Scgb1a1) and surfactant protein c (Sfptc) for stem cells; (5) epithelial cell adhesion molecule (Epcam) as markers of differentiated airway and alveolar epithelium. Epcam, Sfptb and Aqp5 gene expression was increased in both conditions compared to the single cell group. On the other hand, aquaporin 5 expression was greater in the differentiated medium condition compared with organoids exposed to undifferentiated medium. We also observed an increase in the expression of the Sfptc marker in the differentiated condition. Futhermore, fibroblast and stem cells appear to be poorly represented in organoids, indeed the following markers platelet-derived growth factor alpha (Pdgfrα) and secretoglobin family 1A member 1 (Scgb1a1) are weakly expressed. Conclusion Our results show alveolar organoids derived mouse lung present both AT1 and AT2 cells. So, these organoids can used as multicellular experimental models for studying cigarette smoke damage.

Modeling lung diseases using reversibly immortalized mouse pulmonary alveolar type 2 cells (imPAC2)

Alveolar Type Ii Cells Possess The Capability Of Initiating Lung Tumor Development

Alveolar Organoids in Lung Disease Modeling

A New Immortalized Human Alveolar Epithelial Cell Model to Study Lung Injury and Toxicity on a Breathing Lung-On-Chip System

Alveolar wars: The rise of in vitro models to understand human lung alveolar maintenance, regeneration, and disease

Ex Vivotissue Perturbations Coupled to Single Cell RNA-seq Reveal Multi-Lineage Cell Circuit Dynamics in Human Lung Fibrogenesis

Ex vivo modeling of human lung fibrogenesis and drug mode of action screens using single cell RNA-seq in precision-cut lung slices

Characterization an in vitro 3D alveolar model in COPD

Development of human alveolar epithelial cell models to study distal lung biology and disease

A novel human fetal lung-derived alveolar organoid model reveals mechanisms of surfactant protein C maturation relevant to interstitial lung disease

GRAMD2+ alveolar type I cell plasticity facilitates cell state transitions in organoid culture

Organoid-based expansion of patient-derived primary alveolar type 2 cells for establishment of alveolus epithelial Lung-Chip cultures

Organoid modeling of human fetal lung alveolar development reveals mechanisms of cell fate patterning and neonatal respiratory disease

Airway derived emphysema-specific alveolar type II cells exhibit impaired regenerative potential in COPD

Recapitulating idiopathic pulmonary fibrosis related alveolar epithelial dysfunction in a human iPSC‐derived air‐liquid interface model

Modeling of lung phenotype of Hermansky–Pudlak syndrome type I using patient-specific iPSCs

Human iPSC-based model of COPD to investigate disease mechanisms, predict SARS-COV-2 outcome and test preventive immunotherapy

An Optimized Protocol for the Generation of Alveolospheres from Wild-Type Mice

Human pluripotent stem cell modeling of alveolar type 2 cell dysfunction caused by ABCA3 mutations

Temporo-spatial cellular atlas of the regenerating alveolar niche in idiopathic pulmonary fibrosis

restrains an oncogenic epigenetic circuit in AT2 cells to prevent ectopic formation of fibrogenic transitional cell intermediates and pulmonary fibrosis